Incyte Corporation (BIT:1INCY)
57.50
0.00 (0.00%)
At close: Jul 18, 2025, 5:30 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
JAKAFI | 2.79B | Log In | Log In | Log In | Log In | Upgrade |
JAKAFI Growth | 13.31% | Log In | Log In | Log In | Log In | Upgrade |
JAKAVI Product Royalty | 418.84M | Log In | Log In | Log In | Log In | Upgrade |
JAKAVI Product Royalty Growth | 10.75% | Log In | Log In | Log In | Log In | Upgrade |
Milestone and Contract | 43.00M | Log In | Log In | Log In | Log In | Upgrade |
Milestone and Contract Growth | - | Log In | Log In | Log In | Log In | Upgrade |
ICLUSIG | 114.32M | Log In | Log In | Log In | Log In | Upgrade |
ICLUSIG Growth | -0.67% | Log In | Log In | Log In | Log In | Upgrade |
OLUMIANT Product Royalty | 135.57M | Log In | Log In | Log In | Log In | Upgrade |
OLUMIANT Product Royalty Growth | 2.42% | Log In | Log In | Log In | Log In | Upgrade |
PEMAZYRE | 81.75M | Log In | Log In | Log In | Log In | Upgrade |
PEMAZYRE Growth | 4.65% | Log In | Log In | Log In | Log In | Upgrade |
TABRECTA Product Royalty | 22.75M | Log In | Log In | Log In | Log In | Upgrade |
TABRECTA Product Royalty Growth | 26.92% | Log In | Log In | Log In | Log In | Upgrade |
OPZELURA | 508.29M | Log In | Log In | Log In | Log In | Upgrade |
OPZELURA Growth | 47.47% | Log In | Log In | Log In | Log In | Upgrade |
MINJUVI | 119.24M | Log In | Log In | Log In | Log In | Upgrade |
MINJUVI Growth | 129.73% | Log In | Log In | Log In | Log In | Upgrade |
Other Product Royalty | 2.17M | Log In | Log In | Log In | Log In | Upgrade |
Other Product Royalty Growth | 37.38% | Log In | Log In | Log In | Log In | Upgrade |
ZYNYZ | 3.19M | Log In | Log In | Log In | Log In | Upgrade |
ZYNYZ Growth | 233.55% | Log In | Log In | Log In | Log In | Upgrade |